Search results
Celltrion Healthcare will shape a healthier and happier future for humanity by offering high-quality biologics. Celltrion Healthcare offers biologics to about 110 countries, along with more than 30 global partners around the world.
Celltrion provides one-stop solutions for the entire process of biopharmaceutical business from R&D to clinical trials, regulatory affairs, production and distribution. Read more.
Aug 12, 2020 · CELLTRION ASIA PACIFIC PTE. LTD. was incorporated on 12 August 2020 (Wednesday) as a Private Company Limited by Shares in Singapore. The Company current operating status is live with registered address at THE CENTRAL. The Company principal activity is in WHOLESALE OF MEDICINAL AND PHARMACEUTICAL PRODUCTS (WESTERN).
Celltrion has an overall rating of 3.3 out of 5, based on over 120 reviews left anonymously by employees. 41% of employees would recommend working at Celltrion to a friend and 39% have a positive outlook for the business.
Celltrion, with an annual production capacity of 250,000L, is the largest manufacturer and exporter of biosimilars in Korea. Along with Remsima, Celltrion's first product, most products on the top 10 export performance list are Celltrion products.
The number of countries where Celltrion Healthcare’s core biosimilars are available for purchase(and officially approved, 2019). 1 trillion(KRW) The annual value of Remsima ®
Celltrion Inc | 75,770 followers on LinkedIn. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines through an extensive global network that spans...
